Vitasense Raises Funding from Crown Wealth
Summary
Vitasense, a Philadelphia, PA-based startup dedicated to developing non-invasive wearable glucose monitoring technology, raised funding from Crown Wealth, with collaboration from KB Global Holding Limited and other universities. The amount of the deal was not disclosed. The company intends to use the funds to refine its third-generation prototype, enhance regulatory compliance efforts, and prepare for large-scale clinical testing. Founded and led by Max Kopp, VitaSense provides a glucose monitoring armband, which addresses the issue of undiagnosed diabetes by offering a non-invasive and pain-free alternative to traditional finger pricking methods. Utilizing advanced materials like Germanium Selenide (GeSe) nanomaterials, photoplethysmography, and semiconductor-based sensors, the device ensures accurate and real-time glucose level monitoring without the discomfort associated with needles.